David Coman is Chief Executive Officer at BGBx, where he leads the organization’s strategic direction, growth, innovation, and client impact across the life sciences industry. He focuses on helping organizations navigate an increasingly complex healthcare landscape by aligning data, technology, and commercial strategy to drive measurable business outcomes.
David Coman, CEO, BGBX Group, explains how the firm's rebranding reflects a broader shift in biopharma commercialization, where integrating consulting, communications, and a three-dimensional science framework is increasingly necessary for companies.
